• Leonardo F. JuradoEmail author
  • Rocío del Pilar López-Panqueva


During the last 30 years, advances in intensive and critical care units, organ transplantation, concomitant use of immunosuppressive drugs, and increasing prevalence of chronic diseases, malnutrition, and other debilitating conditions, as well as the human immunodeficiency virus pandemic, have increased the incidence of systemic mycotic diseases, the most serious form of fungal diseases are the ones that comprise the central nervous system, representing the most dangerous clinical situations. In those cases, starting an adequate therapy through a rapid and assertive diagnosis is absolutely necessary. Considering the fastidious microbiological nature of some fungi (longtime requirement, specific culture conditions, and biohazard issues), as well as the lack of alternative testing availability, a rapid diagnosis is always challenging. When a tissue or liquid specimen is available, its pathological analysis constitutes a rapid and cost-effective way to provide a presumptive or definitive diagnosis of an invasive fungal infection; however, microbiologists, pathologists, and clinicians need to be aware of the limitations of microscopical diagnosis. In this chapter, we review the usual histological presentation of the most frequent central nervous system fungal infections.


Aspergillus species Blastomyces dermatitis Central nervous system Candida species Coccidioides species Cryptococcus species Histopathology Histoplasma species Mucor species Neuropathology Rhizopus species 



Acquired immunodeficiency syndrome


Broncoalveolar lavage


Central nervous system


Cerebrospinal fluid


Human immunodeficiency virus


Periodic acid-Schiff


  1. Adam RD, Elliott SP, Taljanovicc MS. The spectrum and presentation of disseminated coccidioidomycosis. Am J Med. 2009;122:770–7.PubMedPubMedCentralGoogle Scholar
  2. Alexander B, Smith P, Davis R, Perfect J, Reller L. The (1, 3)-D glucan test as an aid to the early diagnosis of invasive fungal infections following lung transplantation. J Clin Microbiol. 2010;48(11):4083–8. Scholar
  3. Ampel NM. Coccidioidomycosis: a review of recent advances. Clin Chest Med. 2009;30:241–51.CrossRefGoogle Scholar
  4. Antinori S, Corbellino M, Meroni L, Resta F, Sollima S, Tonolini M, Tortorano AM, Milazzo L, Bello L, Furfaro E, Galli M, Viscoli C. Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect. 2013;66:218–38.CrossRefGoogle Scholar
  5. Bariola J, Perry P, Pappas PG, Proia L, Shealey W, Wright PW, Sizemore JM, Matthew Robinson M, Bradsher RW. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis. 2010;50:797–804.CrossRefGoogle Scholar
  6. Barrera-Herrera LE, Vera A, Álvarez J, Lopez R. Necrotizing encephalitis caused by disseminated Aspergillus infection after orthotopic liver transplantation. Case Rep Gastroenterol. 2015;9(1):1–6. Scholar
  7. Ben-Ami R, Luna M, Lewis RE, Walsh TJ, Kontoyiannis DP. A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response. J Infect. 2009;59:134–8.CrossRefGoogle Scholar
  8. Bennett JW. Aspergillus: a primer for the novice. Med Mycol. 2009;47:S5–S12.CrossRefGoogle Scholar
  9. Brumble LM, Reza MB, Dhakal LP, Cruz G, Saleh OMA. Fungal infections of the central nervous system: clinical, radiographic and laboratory manifestations. J Microbiol Exp. 2017;5(6):00167. Scholar
  10. Bueno-Fischer G, Mocelin H, Severo CB, Oliveira F d M, Xavier MO, Severo LC. Histoplasmosis in children. Paediatr Respir Rev. 2009;10:172–7.CrossRefGoogle Scholar
  11. Chong GM, Maertens JA, Lagrou K, Driessen GJ, Cornelissen JJ, Rijnders BJ. Diagnostic performance of galactomannan antigen testing in cerebrospinal fluid. J Clin Microbiol. 2016;54:428–31.CrossRefGoogle Scholar
  12. Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol. 2011;49:785–98.PubMedPubMedCentralGoogle Scholar
  13. Concia E, Azzini AM, Conti M. Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs. 2009;69(Suppl 1):5–14.CrossRefGoogle Scholar
  14. Darouiche RO. Candida in the ICU. Clin Chest Med. 2009;30:287–93.CrossRefGoogle Scholar
  15. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Mu-oz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–21. Scholar
  16. van de Veerdonk FL, Kullberg BJ, Mihai N. Pathogenesis of invasive candidiasis. Curr Opin Crit Care. 2010;16(5):453–45. Scholar
  17. Durkin MJ, Witt A, LeMonte A, Wheat B, Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol. 2004;42:4873–5.CrossRefGoogle Scholar
  18. Durkin M, Connolly P, Kuberski T, Myers R, Kubak BM, Bruckner D, Pegues D, Wheat LJ. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin Infect Dis. 2008;47:e69–73.CrossRefGoogle Scholar
  19. Fennelly AM, Slenker AK, Murphy LC, Moussouttas M, DeSimone JA. Candida cerebral abscesses: a case report and review of the literature. Med Mycol. 2013;51:779–84.CrossRefGoogle Scholar
  20. Galanis E, MacDougall L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007. Emerg Infect Dis. 2010;16:251–7.CrossRefGoogle Scholar
  21. Gavito-Higuera J, Mullins CB, Ramos-Duran L, Olivas Chacon CI, Hakim N, Palacios E. Fungal infections of the central nervous system: a pictorial review. J Clin Imaging Sci. 2016;6:24. Scholar
  22. Gazzoni AF, Severo CB, Salles EF, Severo LC. Histopathology, serology and cultures in the diagnosis of cryptococcosis. Rev Inst Med Trop Sao Paulo. 2009;51:255–9.CrossRefGoogle Scholar
  23. Gilchrist TC. Protozoan dermatitis. J Cutan Genitourin Dis. 1894;12:496–9.Google Scholar
  24. Gilchrist TC, Stokes WR. Case of pseudo-lupus vulgaris caused by Blastomyces. J Exp Med. 1898;3:53–78.CrossRefGoogle Scholar
  25. Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev. 2011;24(2):247–80. Scholar
  26. Gupta N, Arora S, Rajwanshi A, Nijhawan R, Srinivasan R. Histoplasmosis: cytodiagnosis and review of literature with special emphasis on differential diagnosis on cytomorphology. Cytopathology. 2009;–2303.2009.00693.x.
  27. Hage CA, Bowyer S, Tarvin SE, Helper D, Kleiman MB, Wheat LJ. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker herapy. Clin Infect Dis. 2010;50:85–92.CrossRefGoogle Scholar
  28. Hofman V, Dhouibi A, Butori C, Padovani B, Gari-Toussaint M, Garcia-Hermoso D, Baumann M, Vénissac N, Cathomas G, Hofman P. Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient. Diagn Pathol. 2010;5:1–7.CrossRefGoogle Scholar
  29. Huston SM, Mody CH. Cryptococcosis: an emerging respiratory mycosis. Clin Chest Med. 2009;30:253–64.CrossRefGoogle Scholar
  30. Johnson LB, Bradley SF, Kauffman CA. Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses. 1998;41:277–80.CrossRefGoogle Scholar
  31. Kauffman CA. Diagnosis of histoplasmosis in immunosuppressed patients. Curr Opin Infect Dis. 2008;21:421–5.CrossRefGoogle Scholar
  32. Kauffman CA. Histoplasmosis. Clin Chest Med. 2009;30:217–25.CrossRefGoogle Scholar
  33. Kordossis T, Avlami A, Velegraki A, Stefanou I, Georgakopoulos G, Papalambrou C, Legakis NJ. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Med Mycol. 1998;36:335–9.CrossRefGoogle Scholar
  34. Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373:1445–56.CrossRefGoogle Scholar
  35. Lammering JC, Iv M, Gupta N, Pandit R, Patel MR. Imaging spectrum of CNS coccidioidomycosis: prevalence and significance of concurrent brain and spinal disease. AJR Am J Roentgenol. 2013;200:1334–46.CrossRefGoogle Scholar
  36. Lau A, Halliday C, Chen SC, Playford EG, Stanley K, Sorrell TC. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol. 2010;48:811–6.CrossRefGoogle Scholar
  37. Lee S, Yun NR, Kim KH, Jeon JH, Kim EC, Chung DH, Park WB, Oh MD. Discrepancy between histology and culture in filamentous fungal infections. Med Mycol. 2010;48:886–8.CrossRefGoogle Scholar
  38. Lemos LB, Guo M, Baliga M. Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi. Ann Diagn Pathol. 2000;4:391–406.CrossRefGoogle Scholar
  39. Li L, Dial SM, Schmelz M, Rennels MA, Ampel NM. Cellular immune suppressor activity resides in lymphocyte cell clusters adjacent to granulomata in human coccidioidomycosis. Infect Immun. 2005;73:3923–8.CrossRefGoogle Scholar
  40. Liu X, Ling Z, Li L, Ruan B. Invasive fungal infections in liver transplantation. Int J Infect Dis. 2011;15(5):e298–304.CrossRefGoogle Scholar
  41. Loulergue P, Bastides F, Baudouin V, Chandenier J, Mariani-Kurkdjian P, Dupont B, Viard JP, Dromer F, Lortholary O. Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients. Emerg Infect Dis. 2007;13:1647–52.CrossRefGoogle Scholar
  42. Malo J, Luraschi-Monjagatta C, Wolk DM, Thompson R, Hage CA, Knox KS. Update on the diagnosis of pulmonary coccidioidomycosis. Ann Am Thorac Soc. 2014;11(2):243–53. Scholar
  43. Martynowicz M, Prakash UBS. Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest. 2002;121:768–73.CrossRefGoogle Scholar
  44. Mathur M, Johnson CE, Sze G. Fungal infections of the central nervous system. Neuroimaging Clin N Am. 2012;22(4):609–32.CrossRefGoogle Scholar
  45. May RC, Stone NR, Wiesner DL, Bicanic T, Nielsen K. Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol. 2016;14(2):106–17. Scholar
  46. McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJ. Mold infections of the central nervous system. N Engl J Med. 2014;371:150–60.CrossRefGoogle Scholar
  47. McKinnell JA, Pappas PG. Blastomycosis: new insights into diagnosis, prevention, and treatment. Clin Chest Med. 2009;30:227–39.CrossRefGoogle Scholar
  48. Merwick Á, Minhas Z, Curtis C, Thom M, Choi D, Mummery C. Intradural extramedullary spinal candida infection. Pract Neurol. 2015;15:400–4.CrossRefGoogle Scholar
  49. Mukhopadhyay S, Katzenstein ALA. Biopsy findings in acute pulmonary histoplasmosis: unusual histologic features in 4 cases mimicking lymphomatoid granulomatosis. Am J Surg Pathol. 2010;34:541–6.CrossRefGoogle Scholar
  50. Naggie S, Perfect JR. Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosis. Clin Chest Med. 2009;30:337–53.CrossRefGoogle Scholar
  51. Neilson JB, Fromtling RA, Bulmer GS. Cryptococcus neoformans: size range of infectious particles from aerosolized soil. Infect Immun. 1997;17:634–8.Google Scholar
  52. Nemecek JC, Wuthrich M, Klein BS. Global control of dimorphism and virulence in fungi. Science. 2006;312:583–8.CrossRefGoogle Scholar
  53. Parish JM, Blair JE. Coccidioidomycosis. Mayo Clin Proc. 2008;83:343–9.CrossRefGoogle Scholar
  54. Patel A, Gattuso JP, Reddy VB. Diagnosis of blastomycosis in surgical pathology and cytopathology: correlation with microbiologic culture. Am J Surg Pathol. 2010;34:256–61.CrossRefGoogle Scholar
  55. Perdigao J, Rojas R, Verzelli LF, Castillo M. Fungal infections of the central nervous system. Semin Roentgenol. 2004;39(4):505–18.CrossRefGoogle Scholar
  56. Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. Contribution of the (1→3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2008;46:1009–13.CrossRefGoogle Scholar
  57. Posch W, Heimdörfer D, Wilflingseder D, Lass-Flörl C. Invasive candidiasis: future directions in non-culture based diagnosis. Expert Rev Anti Infect Ther. 2017;15(9):829–38. Scholar
  58. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10(Suppl 1):31–47. Scholar
  59. Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17:873–81.CrossRefGoogle Scholar
  60. Raman-Sharma R. Fungal infections of the nervous system: current perspective and controversies in management. Int J Surg. 2010;8(8):591–601.CrossRefGoogle Scholar
  61. Read RW, Zhang J, Albini T, Evans M, Rao NA. Splendore-Hoeppli phenomenon in the conjunctiva: immunohistochemical analysis. Am J Ophthalmol. 2005;140:262–6.CrossRefGoogle Scholar
  62. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301.CrossRefGoogle Scholar
  63. Riscili BP, Wood KL. Noninvasive pulmonary Aspergillus infections. Clin Chest Med. 2009;30:315–35.CrossRefGoogle Scholar
  64. Rixford E, Gilchrist TC. Two cases of protozoon (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep. 1896;1:209–68.Google Scholar
  65. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.CrossRefGoogle Scholar
  66. Roilides E, Antachopoulos C, Simitsopoulou M. Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs. Mycoses. 2014;57(Suppl 3):40–7. Scholar
  67. Salvatore CM, Chen TK, Toussi SS, De La Mora P, Petraitiene R, Finkelman MA, Walsh TJ. (1→3)-β-D-Glucan in cerebrospinal fluid as a biomarker for Candida and Aspergillus infections of the central nervous system in pediatric patients. J Pediatr Infect Dis Soc. 2016;5(3):277–86. Scholar
  68. Sargent J, O’Marcaigh A, Smith O, Butler K, Gavin P, O’Sullivan M. Candida albicans-associated necrotizing vasculitis producing life-threatening gastrointestinal hemorrhage. Hum Pathol. 2010;41:602–4.CrossRefGoogle Scholar
  69. Sarosi GA, Davies SF. Blastomycosis. State of the art. Am Rev Respir Dis. 1979;120:911–38.PubMedGoogle Scholar
  70. Saubolle MA. Laboratory aspects in the diagnosis of coccidioidomycosis. Ann N Y Acad Sci. 2007;1111:301–14.CrossRefGoogle Scholar
  71. Schuetz AN, Walsh TJ. Importance of fungal histopathology in immunocompromised pediatric patients: it’s not just “Aspergillus” anymore. Am J Clin Pathol. 2015;144(2):185–7. Scholar
  72. Schwartz S, Kontoyiannis DP, Harrison T, Ruhnke M. Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol. 2018;17(4):362–72. Scholar
  73. Segal E, Elad D. Candidiasis. In: Mahy BW, Meulen Borriello VP, Murray PR, Funke G, Kaufmann SH, Steward HM, Merz WG, Hay RJ, Cox F, Wakelin D, Gillespie SH, Despommier DD, editors. Topley & Wilson’s microbiology and microbial infections. New York: Wiley; 2010. Scholar
  74. Sherif R, Segal BH. Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications. Curr Opin Pulm Med. 2010;16:242–50.PubMedPubMedCentralGoogle Scholar
  75. Shukla S, Singh S, Jain M, Kumar Singh S, Chander R, Kawatra N. Paediatric cutaneous blastomycosis: a rare case diagnosed on FNAC. Diagn Cytopathol. 2009;37:119–21.CrossRefGoogle Scholar
  76. Sing Y, Ramdial PK. Cryptococcal inflammatory pseudotumors. Am J Surg Pathol. 2007;31:1521–7.CrossRefGoogle Scholar
  77. Southern P, Horbul J, Maher D, Davis DA. C. albicans colonization of human mucosal surfaces. PLoS One. 2008;3:1–9.CrossRefGoogle Scholar
  78. Sundaram C, Umabala P, Laxmi V, Purohit AK, Prasad VSSV, Panigrahi M, Sahu BP, Sarathi MV, Kaul S, Borghain R, Meena AK, Jayalakshmi SS, Suvarna A, Mohandas S, Murthy JMK. Pathology of fungal infections of the central nervous system: 17 years’ experience from Southern India. Histopathology. 2006;49:396–405. Scholar
  79. Swartzentruber S, Rhodes L, Kurkjian K, Zahn M, Brandt ME, Connolly P, Wheat LJ. Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis. 2009;49:1878–82.CrossRefGoogle Scholar
  80. Vazquez J, Sobel J. Candidiasis. In: Kaufman C, Pappas P, Sobel J, Dismukes W, editors. Essentials of clinical mycology. 2nd ed. Oxford: Oxford University Press; 2011. p. 167–206.CrossRefGoogle Scholar
  81. Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF, Hage C. Histoplasmosis. Infect Dis Clin North Am. 2016;30:207–27. Scholar
  82. Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, Harrison TS. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol. 2017;13:13–24.CrossRefGoogle Scholar
  83. Zimmermann J, Guresir A, Nelles M, Guresir E. Rapid development and rupture of a cerebral mycotic aneurysm in Candida infective endocarditis. Intensive Care Med. 2016;42:275–6.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Leonardo F. Jurado
    • 1
    Email author
  • Rocío del Pilar López-Panqueva
    • 1
    • 2
  1. 1.Pathology and Laboratories DepartmentFundación Santa Fe de Bogotá University HospitalBogotáColombia
  2. 2.School of MedicineLos Andes UniversityBogotáColombia

Personalised recommendations